Case Report: Hormone receptor-positive uterine mesonephric-like adenocarcinoma
Frontiers in Medicine · 20.04.2026 · 13
DOI: 10.3389/fmed.2026.1787557 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Medicine, online erschienen am 20.04.2026. Verfasst von Ting Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Research Institute of Integrated TCM & Western Medicine of Chengdu University of Chinese Medicine, Chengdu Integrated TCM…. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Uterine mesonephric-like adenocarcinoma (MLA) is a rare and biologically aggressive subtype of endometrial carcinoma, estrogen receptor (ER) and progesterone receptor (PR) are typically absent or exhibit very low expression in this type of cancer. The cornerstone of treatment is still surgical resection, frequently in combination with chemotherapy or radiation therapy. There is currently disagreement over the optimal therapeutic regimen. Case presentation A 60-year-old postmenopausal woman presented with vaginal bleeding as the initial symptom. Computed tomography (CT) imaging revealed a uterine mass, and postoperative histopathology confirmed a diagnosis of mesonephric-like adenocarcinoma of the uterus. This case demonstrates dual ER/PR positivity, representing the first reported instance of this rare clinical subtype.
Conclusion
This study aims to enhance clinicians’ recognition and management of uterine mesonephric-like adenocarcinoma. MLA with hormone receptor expression may exhibit distinct biological behavior. Future studies with larger cohorts and longer follow-up are needed to explore whether these tumors could represent a candidate for endocrine-based therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Research Institute of Integrated TCM & Western Medicine of Chengdu University of Chinese Medicine, Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, China.
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Pathology, Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, China.
Zitieren
APA
Luo, T., Shen, J., Zeng, Y., Xie, K., & Xu, N. (2026). Case Report: Hormone receptor-positive uterine mesonephric-like adenocarcinoma. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1787557
Vancouver
Luo T, Shen J, Zeng Y, Xie K, Xu N. Case Report: Hormone receptor-positive uterine mesonephric-like adenocarcinoma. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1787557
BibTeX
@article{Luo2026,
author = {Luo, Ting and Shen, Jianing and Zeng, Yongjun and Xie, Kang and Xu, Nie},
title = {Case Report: Hormone receptor-positive uterine mesonephric-like adenocarcinoma},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1787557}
}
EUVIMED